FIELD: genetic and protein engineering, microbiological and medicinal industry. SUBSTANCE: invention relates to preparing recombinant plasmid DNA pKHBc-33 containing gene of hepatitis B virus core antigen (HBcAg) with the main neutralizing epitope of hepatitis B virus surface antigen (137-147) (HBsAg) exhibited on its surface and the corresponding strain-producer. Plasmid has also structural members that are necessary for hybrid protein expression providing in strain-producer cells. For preparing strain-producer competent cells of bacterium Escherichia coli JM103 are transformed with plasmid pKHBc-33. Obtained strain E. coli JM103/pKHBc-33 provides the induced synthesis of HBcAg-HBsAg (137-147) at expression level 5% of total cell protein. EFFECT: recombinant plasmid preparing. 2 cl, 3 dwg
Authors
Dates
1998-05-27—Published
1995-10-24—Filed